[Congressional Record (Bound Edition), Volume 153 (2007), Part 19]
[Extensions of Remarks]
[Page 27047]
[From the U.S. Government Publishing Office, www.gpo.gov]




                   SALUTING PFIZER AND ITS EMPLOYEES

                                 ______
                                 

                           HON. JOE COURTNEY

                             of connecticut

                    in the house of representatives

                      Wednesday, October 10, 2007

  Mr. COURTNEY. Madam Speaker, I rise today to salute the charitable 
donations of Pfizer and its employees.
  A corporate leader in southeastern Connecticut, Pfizer's world 
research and development headquarters is located in my congressional 
district in Groton, Connecticut. In the August 23 edition of the 
Chronicle of Philanthropy, Pfizer was recognized as the largest 
corporate charitable donor in the United States. The Chronicle's study, 
which encompassed 150 of the largest U.S. businesses outlined in 
Fortune magazine, examined the amount of cash and product donations 
during the past 3 fiscal years.
  During this period, Pfizer and its employees donated more than $1.7 
billion, with pharmaceutical products composing nearly 95 percent of 
the total. In 2006, Pfizer donated nearly $800 million to charities 
abroad, an increase of 92 percent from the previous year. These 
donations have greatly contributed to emergency and long-term health 
needs in developing nations.
  Corporate citizenship and philanthropy have filled a significant role 
in assisting needy groups in our society. As a highly educated, 
compassionate group of people who are devoted to finding cures for 
disease and ailments, it is not surprising that Pfizer's employees are 
leading the way nationally in support of charitable causes.
  As philanthropy becomes an increasingly integral component of 
business practices, we must recognize the importance of corporate 
charitable endeavors and the positive impacts on local, national, and 
international communities. I ask my colleagues to join with me in 
recognizing Pfizer's charitable contributions that have supported 
health and social objectives domestically and abroad.

                          ____________________